These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11861372)

  • 21. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
    J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J; Hunt KK; Mirza NQ; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Ross MI; Ames FC; Feig BW; Singletary SE; Cristofanilli M; Meric-Bernstam F
    Cancer; 2005 Aug; 104(3):479-90. PubMed ID: 15968686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer.
    Xie B; Freudenheim JL; Cummings SS; Singh B; He H; McCann SE; Moysich KB; Shields PG
    Carcinogenesis; 2006 Feb; 27(2):307-10. PubMed ID: 16113052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Antonucci JV; Goldstein N; Wallace M; Kestin L; Krauss D; Kunzmann J; Gilbert S; Schell S
    Cancer; 2007 Apr; 109(7):1264-72. PubMed ID: 17372920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outer breast quadrants demonstrate increased levels of genomic instability.
    Ellsworth DL; Ellsworth RE; Love B; Deyarmin B; Lubert SM; Mittal V; Hooke JA; Shriver CD
    Ann Surg Oncol; 2004 Sep; 11(9):861-8. PubMed ID: 15313734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
    Kunos C; Latson L; Overmoyer B; Silverman P; Shenk R; Kinsella T; Lyons J
    Breast J; 2006; 12(1):28-36. PubMed ID: 16409584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors.
    Goldstein NS; Vicini FA; Hunter S; Odish E; Forbes S; Kraus D; Kestin LL
    Am J Clin Pathol; 2005 May; 123(5):679-89. PubMed ID: 15981807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer recurrences in elderly patients after lumpectomy.
    Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
    Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence.
    Schlechter BL; Yang Q; Larson PS; Golubeva A; Blanchard RA; de las Morenas A; Rosenberg CL
    J Clin Oncol; 2004 May; 22(10):1830-8. PubMed ID: 15143075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer.
    van den Broek N; van der Sangen MJ; van de Poll-Franse LV; van Beek MW; Nieuwenhuijzen GA; Voogd AC
    Breast Cancer Res Treat; 2007 Sep; 105(1):63-8. PubMed ID: 17115109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.